CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways The Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association Major infections after bypass surgery and stenting: an overlooked but fatal complication

Guideline2016 Sep 27;68(13):1476-1488.

JOURNAL:J Am Coll Cardiol. Article Link

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure

Yancy CW, Jessup M, Bozkurt B et al. Keywords: ACC/AHA Clinical Practice Guidelines; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; focused update; heart failure; ivabradine; natriuretic peptides

Full Text PDF